Delivery Order SPE2DR25D3005-SPE2DR26FP8QC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,786.36 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of January 7, 2026, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Yuvafem 10 MCG vaginal insert (18-count) under a firm fixed-price contract with a ceiling value of $1,240.42. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of January 5, 2026. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,803.36 delivery order on December 30, 2025, for Yuvafem 10 mcg vaginal inserts (18 units). This is a firm fixed-price, non-set-aside contract with a completion date of December 31, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.12 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg Vaginal Insert (18-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The awardee is a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.30 to Amerisourcebergen Drug Corp for Yuvafem 10 microgram vaginal inserts (18-pack) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $2,696.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Yuvafem 10 microgram vaginal inserts (18 count). This is a non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Yuvafem 10 microgram vaginal inserts (18-count package) with a ceiling value of $4,331.20. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,352.04 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, competitively awarded delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.49 to AmerisourceBergen Drug Corp for Yuvafem 10 micrograms vaginal inserts (8-count package) on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8QCDelivery Order
On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,132.40 to AmerisourceBergen Drug Corp for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 15, 2026, and performance will be executed from the awardee's location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent organization, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime IDC serves as the vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving Defense Health Agency and military healthcare systems. The company regularly fulfills competitively awarded delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order represents a routine, small-value procurement of pharmaceutical products typical of the company's extensive portfolio of federal medical supply contracts, demonstrating its continued role as a key supplier in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/13/26 |